Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Antimicrobial, Anti-TB, Anticancer and Anti-HIV Evaluation of New <i>s</i> -Triazine-Based Heterocycles — Rahul V. Patel (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Antimicrobial, Anti-TB, Anticancer and Anti-HIV Evaluation of New <i>s</i> -Triazine-Based Heterocycles
Shared by
De Clercq Erik
KU Leuven
Antimicrobial, Anti-TB, Anticancer and Anti-HIV Evaluation of New <i>s</i> -Triazine-Based Heterocycles
Article
2012
en
Authors
+3 more
RP
Rahul V. Patel
PK
Premlata Kumari
DR
Dhanji P. Rajani
Abstract
1 min read
Activity profiles of the products may contribute considerably to future drug-discovery studies.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2014
Different Heterocycles Functionalized <i>s</i>‐Triazine Analogues: Design, Synthesis and <i>In Vitro</i> Antimicrobial, Antituberculosis, and Anti‐HIV Assessment
Paresh K. Patel
,
Rahul V. Patel
,
Dharmesh H. Mahajan
,
Parimal A. Parikh
,
Girish Mehta
,
Christophe Pannecouque
,
De Clercq Erik
,
Kishor H. Chikhalia
Article
2013
Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline–triazine derivatives
Rahul P. Modh
,
De Clercq Erik
,
Christophe Pannecouque
,
Kishor H. Chikhalia
Article
2001
New 3‘-Azido-3‘-deoxythymidin-5‘-yl <i>O</i>-(<i>ω</i>-Hydroxyalkyl) Carbonate Prodrugs: Synthesis and Anti-HIV Evaluation
Patrick Vlieghe
,
Frédéric Bihel
,
Thierry Clerc
,
Christophe Pannecouque
,
Myriam Witvrouw
,
De Clercq Erik
,
Jean‐Pierre Salles
,
Jean‐Claude Chermann
,
Jean‐Louis Kraus
Article
2024
Rapid identification of novel indolylarylsulfone derivatives as potent HIV-1 NNRTIs <i>via</i> miniaturized CuAAC click-chemistry-based combinatorial libraries
Ping Gao
,
Shu Song
,
Christophe Pannecouque
,
De Clercq Erik
,
Peng Zhan
,
Xinyong Liu
Article
2021
Approved HIV reverse transcriptase inhibitors in the past decade
Guangdi Li
,
Yali Wang
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.